WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2018100036) ANALYSIS OF ANTI-ERYTHROCYTE ANTIBODY IN THE PRESENCE OF ANTIBODY DIRECTED AGAINST A SURFACE-BOUND ERYTHROCYTE ANTIGEN
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.: WO/2018/100036 International Application No.: PCT/EP2017/080926
Publication Date: 07.06.2018 International Filing Date: 30.11.2017
IPC:
G01N 33/80 (2006.01)
Applicants: IMUSYN GMBH & CO. KG[DE/DE]; Feodor-Lynen-Str. 5 30625 Hannover, DE
Inventors: SCHNEEWEISS, Clemens; DE
GRÜGER, Daniela; DE
Agent: TARUTTIS, Stefan; DE
Priority Data:
16201819.601.12.2016EP
17150738.709.01.2017EP
Title (EN) ANALYSIS OF ANTI-ERYTHROCYTE ANTIBODY IN THE PRESENCE OF ANTIBODY DIRECTED AGAINST A SURFACE-BOUND ERYTHROCYTE ANTIGEN
(FR) ANALYSE D’ANTICORPS ANTI-ÉRYTHROCYTE EN PRÉSENCE D’UN ANTICORPS DIRIGÉ CONTRE UN ANTIGÈNE DE SURFACE D’ÉRYTHROCYTE
Abstract:
(EN) An analytical process for detecting antibody in human blood serum, which antibody is directed against blood group antigen, wherein the serum contains an additional antibody directed against a surface antigen, by contacting the serum to be analysed with blood cell membranes, which naturally bear surface blood group antigens, followed by detection of agglutination which indicated the presence of antibody directed against at least one surface antigen of the blood cell membranes. The agglutination reaction caused by the additional antibody is prevented, allowing the detection of anti-blood group antibody.
(FR) La présente invention concerne un procédé analytique pour détecter un anticorps dans le sérum sanguin humain, ledit anticorps étant dirigé contre un antigène de groupe sanguin, le sérum contenant un anticorps supplémentaire dirigé contre un antigène de surface, par mise en contact du sérum à analyser avec des membranes de cellules sanguines, qui comportent naturellement des antigènes de groupe sanguin de surface, suivi d’une détection d’agglutination qui indique la présence d’un anticorps dirigé contre au moins un antigène de surface des membranes de cellules sanguines. La réaction d’agglutination causée par l’anticorps supplémentaire est inhibée, de façon à permettre la détection d’un anticorps de groupe sanguin.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)